1399182-83-2

Upstream product

• 1399182-82-1 4-cyclobutyl-5-(5-methoxy-4H-1,2,4-triazol-3-yl)-2-methylbenzamide 
• 1399182-81-0 4-cyclobutyl-5-(5-methoxy-4H-1,2,4-triazol-3-yl)-2-methylbenzonitrile 
• 1399182-77-4 5-(5-amino-1,3,4-oxadiazol-2-yl)-4-cyclobutyl-2-methylbenzonitrile 
• 1399182-76-3 5-cyano-2-cyclobutyl-4-methylbenzohydrazide 
• 1399182-75-2 methyl 5-cyano-2-cyclobutyl-4-methylbenzoate 
• 1399182-74-1 methyl 2-cyclobutyl-5-iodo-4-methylbenzoate 
• 1399182-73-0 methyl 2-cyclobutyl-4-methylbenzoate 
• 7697-27-0 2-bromo-4-methylbenzoic acid 
• 87808-49-9 2-bromo-4-methyl-benzoic acid methyl ester 

Downstream Products

• 1399178-07-4 4-(1-(4-cyclobutyl-5-(5-methoxy-4H-1,2,4-triazol-3-yl)-2-methylbenzoyl)piperidin-4-yl)benzonitrile 

Relevant academic research and scientific papers

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are